L&K Biomed Ltd.
Research L&K Biomed Ltd. (156100.KQ) on Bullrun: market cap KRW 125.17B. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker156100.KQ
- ExchangeKQ
- CountrySouth Korea
- SectorHealthcare
- IndustryMedical Devices
- CurrencyKRW
- Market capKRW 125.17B
- Financial periodQ2 2026
- RevenueKRW 11.74B
- Net incomeKRW 7.57B
- Free cash flow-KRW 816.93M
- Gross margin83.7%
Valuation Snapshot
latest market cap is KRW 125.17B.
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | KRW 125.17B | n/a | n/a | n/a |
Dividend history
About L&K Biomed Ltd.
L&K Biomed Ltd., engages in the manufacturing, production, and sales of medical devices in South Korea, the United States, Thailand, and internationally. The company offers spinal products comprising BlueEX-T, BluEX-TC, BluEX-A, BlueEX-L, and BluEX-ATP; BluEX-LT, an advanced lateral cage system for spinal lordosis restoration; PathLoc-TM, an expandable TLIF/PLIF lumbar cage system; AccelFix-XL, an expandable lateral lumbar cage system; AccelFix-XTP, an expandable lumbar cage system for anterior-to-psoas approach;
Related stock research
Other Healthcare stocks
Frequently asked questions
What is L&K Biomed Ltd.'s market cap?
L&K Biomed Ltd.'s market capitalization is KRW 125.17B.
What does L&K Biomed Ltd. do?
L&K Biomed Ltd., engages in the manufacturing, production, and sales of medical devices in South Korea, the United States, Thailand, and internationally. The company offers spinal products comprising BlueEX-T, BluEX-TC, BluEX-A, BlueEX-L, and BluEX-ATP; BluEX-LT, an advanced lateral cage system for spinal lordosis restoration; PathLoc-TM, an expandable TLIF/PLIF lumbar cage system; AccelFix-XL, an expandable lateral lumbar cage system; AccelFix-XTP, an expandable lumbar cage system for anterior-to-psoas approach; and PathLoc-TA, an expandable ALIF anterior lumbar cage system.